<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is a new window to therapy of many diseases </plain></SENT>
<SENT sid="1" pm="."><plain>From March 1991 through April 2011, a total of 3237 HSCT were performed in the Hematology-<z:hpo ids='HP_0002664'>Oncology</z:hpo> and Stem Cell Transplantation Research Center, affiliated to Tehran University of Medical Sciences </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report 20 years experience of HSCT </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVES: Our strategy and aim include the protraction of cytogenetic and molecular biological diagnostic tests, the expansion of the first Iranian Cord Blood Bank (ICBB) and development of the first Iranian Stem Cell Donor Program (ISCDP), and improvement the researches in new therapeutic fields </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENTS AND METHODS: Totally, 3237 patients were undergone HSCT </plain></SENT>
<SENT sid="5" pm="."><plain>Of these transplants, 2205 were allogeneic stem cell transplantation, 1016 autologous and 16 syngeneic </plain></SENT>
<SENT sid="6" pm="."><plain>Among 2205 patients who were undergone allogenic-HSCT, 34 received cord blood stem cells as stem cell source for transplantation </plain></SENT>
<SENT sid="7" pm="."><plain>It is important to point out that cord blood bank at our center provides reliable storage of cord blood stem cells for our patients </plain></SENT>
<SENT sid="8" pm="."><plain>Stem cell transplantation was performed for treatment of various diseases such as <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo>, <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">beta-thalassemia major</z:e>, <z:e sem="disease" ids="C0221019" disease_type="Disease or Syndrome" abbrv="">sickle- cell thalassemia</z:e>, <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle- cell disease</z:e>, <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, <z:e sem="disease" ids="C0026703" disease_type="Disease or Syndrome" abbrv="">mucopolysaccharidosis</z:e>, <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo>, non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, plasma cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:e sem="disease" ids="C0028064" disease_type="Disease or Syndrome" abbrv="">Niemann-Pick disease</z:e>, Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo>, <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo>, <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo>, <z:e sem="disease" ids="C0272187" disease_type="Disease or Syndrome" abbrv="">leukocyte adhesion deficiencies</z:e>, <z:e sem="disease" ids="C0007965" disease_type="Disease or Syndrome" abbrv="">Chediak-Higashi syndrome</z:e>, <z:hpo ids='HP_0011002'>osteopetrosis</z:hpo>, <z:mpath ids='MPATH_653'>histiocytosis X</z:mpath>, <z:e sem="disease" ids="C0086795" disease_type="Disease or Syndrome" abbrv="">Hurler syndrome</z:e>, <z:hpo ids='HP_0011034'>amyloidosis</z:hpo>, systemic <z:mp ids='MP_0000612'>sclerosis</z:mp>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, Ewing's <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, <z:e sem="disease" ids="C0153594" disease_type="Neoplastic Process" abbrv="">testicular cancer</z:e>, <z:mpath ids='MPATH_310'>germ cell tumors</z:mpath>, <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>, <z:hpo ids='HP_0002885'>medulloblastoma</z:hpo>, <z:hpo ids='HP_0005584'>renal cell carcinoma</z:hpo>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovarian cancer</z:e>, <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>, <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo>, <z:hpo ids='HP_0100757'>pancreatoblastoma</z:hpo>, and multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Also, we had 220 cellular therapies for post-<z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, multiple <z:mp ids='MP_0000612'>sclerosis</z:mp>, <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, head of femur <z:mp ids='MP_0001651'>necrosis</z:mp>, <z:hpo ids='HP_0000819'>Diabetes Mellitus</z:hpo> and GvHD treatment </plain></SENT>
<SENT sid="10" pm="."><plain>45 patients were undergone retransplantation in this center </plain></SENT>
<SENT sid="11" pm="."><plain>RESULTS: About 78.2% of the patients (2530 of 3237) remained alive between one to 211 months after stem cell transplantation </plain></SENT>
<SENT sid="12" pm="."><plain>Nearly, 21.8% (707) of our patients died after stem cell transplantation </plain></SENT>
<SENT sid="13" pm="."><plain>The main causes of <z:hpo ids='HP_0011420'>death</z:hpo> were relapse, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, <z:e sem="disease" ids="C0085692" disease_type="Disease or Syndrome" abbrv="">hemorrhagic cystitis</z:e>, <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus- host disease</z:e> and etc </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: In Iran, HSCT has been successfully adapted in routine clinical care </plain></SENT>
<SENT sid="15" pm="."><plain>Recently, new methods such as double cord blood and haploidentical transplantation have been used to treat many life-threatening diseases </plain></SENT>
</text></document>